Udg Healthcare (UDG) Hits New 52-Week Low at $623.50

Shares of Udg Healthcare PLC (LON:UDG) reached a new 52-week low on Thursday . The stock traded as low as GBX 623.50 ($8.15) and last traded at GBX 626 ($8.18), with a volume of 1153802 shares trading hands. The stock had previously closed at GBX 644.50 ($8.42).

UDG has been the subject of several recent research reports. Numis Securities restated a “reduce” rating on shares of Udg Healthcare in a research report on Wednesday, August 8th. Barclays restated an “equal weight” rating on shares of Udg Healthcare in a research report on Friday, September 28th. Liberum Capital restated a “buy” rating and set a GBX 884 ($11.55) price target on shares of Udg Healthcare in a research report on Wednesday, August 8th. Peel Hunt restated a “buy” rating on shares of Udg Healthcare in a research report on Friday, August 24th. Finally, Jefferies Financial Group upgraded shares of Udg Healthcare to a “buy” rating and lowered their price target for the stock from GBX 895 ($11.69) to GBX 890 ($11.63) in a research report on Thursday, August 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. Udg Healthcare presently has an average rating of “Hold” and a consensus price target of GBX 850.67 ($11.12).

In other news, insider Peter Gray purchased 14,000 shares of the stock in a transaction dated Wednesday, September 19th. The stock was acquired at an average price of GBX 631 ($8.25) per share, for a total transaction of £88,340 ($115,431.86).

About Udg Healthcare (LON:UDG)

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.

Read More: Asset Allocation, Balancing Your Investments

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply